Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of INVO Fertility Inc (NASDAQ: IVF) was $0.49 for the day, down -4.66% from the previous closing price of $0.51. In other words, the price has decreased by -$4.66 from its previous closing price. On the day, 0.74 million shares were traded. IVF stock price reached its highest trading level at $0.54 during the session, while it also had its lowest trading level at $0.49.
Ratios:
Our analysis of IVF’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.10 and its Current Ratio is at 0.11. In the meantime, Its Debt-to-Equity ratio is 2.71 whereas as Long-Term Debt/Eq ratio is at 1.18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVF now has a Market Capitalization of 2761390 and an Enterprise Value of 18840104. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42. Its current Enterprise Value per Revenue stands at 2.846 whereas that against EBITDA is -2.816.
Stock Price History:
The Beta on a monthly basis for IVF is 2.02, which has changed by -0.98176616 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, IVF has reached a high of $37.44, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -42.52%, while the 200-Day Moving Average is calculated to be -91.22%.
Shares Statistics:
IVF traded an average of 4.85M shares per day over the past three months and 27384200 shares per day over the past ten days. A total of 5.62M shares are outstanding, with a floating share count of 5.53M. Insiders hold about 1.71% of the company’s shares, while institutions hold 0.16% stake in the company. Shares short for IVF as of 1760486400 were 37641 with a Short Ratio of 0.01, compared to 1757894400 on 32512. Therefore, it implies a Short% of Shares Outstanding of 37641 and a Short% of Float of 0.86.
Earnings Estimates
Analysts are recommending an EPS of between -$3.33 and -$3.33 for the fiscal current year, implying an average EPS of -$3.33. EPS for the following year is -$2.94, with 1.0 analysts recommending between -$2.94 and -$2.94.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $1.89M. There is a high estimate of $1.89M for the next quarter, whereas the lowest estimate is $1.89M.
A total of 1 analysts have provided revenue estimates for IVF’s current fiscal year. The highest revenue estimate was $6.98M, while the lowest revenue estimate was $6.98M, resulting in an average revenue estimate of $6.98M. In the same quarter a year ago, actual revenue was $6.53MBased on 1 analysts’ estimates, the company’s revenue will be $7.68M in the next fiscal year. The high estimate is $7.68M and the low estimate is $7.68M.
